Arkolith/Insider Trading/RPRX/Form 4

Lloyd George W.

EVP, Investments & CLORoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.2M
Net Open-Market Flow
-$4.2M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Sell(S)31K$38.50$1.2M0
Dec 17, 2025Sell(S)79K$38.57$3.1M31K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814899-25-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML